Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs.

Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs.

The anthracyclines, such as doxorubicin (DXR), are potent anti-cancer drugs but they are limited by their clinical toxicity. The mechanisms involved remain poorly understood partly because of the difficulty in determining sub-cellular drug localisation. Using a novel method utilising the fluorescent...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Ashley, N, Poulton, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

Targeting DNA with Anthracyclines: The Importance of the Sugar Moiety
de réir: Waldemar Priebe
Foilsithe / Cruthaithe: (2000-03-01)

Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.
de réir: Ashley, N, et al.
Foilsithe / Cruthaithe: (2009)

Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
de réir: Junqi Huang, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer
de réir: Craig Davison, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
de réir: Alessandra Murabito, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
de réir: Xiaohang Qiao, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Anthracyclines, proteasome activity and multi-drug-resistance
de réir: Pajonk Frank, et al.
Foilsithe / Cruthaithe: (2005-09-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
de réir: V. I. Chernov, et al.
Foilsithe / Cruthaithe: (2016-02-01)

Anthracyclines
de réir: Alison Cheong, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Anthracycline cardiomyopathy
de réir: Vasiliy Nefedovich Anokhin, et al.
Foilsithe / Cruthaithe: (2011-10-01)

Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances
de réir: Ashley, N, et al.
Foilsithe / Cruthaithe: (2007)

Creation of anthracycline prodrug
de réir: A. N. Tevyashova
Foilsithe / Cruthaithe: (2014-12-01)

Cardiotoxicity of Anthracyclines
de réir: Daniela Cardinale, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Anthracycline Cardiotoxicity
de réir: Umberto Campia, MD, MSc, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Off-Target Effects of Drugs that Disrupt Human Mitochondrial DNA Maintenance
de réir: Matthew J. Young
Foilsithe / Cruthaithe: (2017-11-01)

Nuclear transfer to prevent mitochondrial DNA diseases.
de réir: Poulton, J, et al.
Foilsithe / Cruthaithe: (2006)

Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer
de réir: Yuhan Wei, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
de réir: Murat Bardakci, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
de réir: Jacqueline T. Vuong, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration.
de réir: Isao eIshii, et al.
Foilsithe / Cruthaithe: (2012-10-01)

Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
de réir: Jeannette R. Wong-Siegel, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Preventing transmission of maternally inherited mitochondrial DNA diseases
de réir: Poulton, J, et al.
Foilsithe / Cruthaithe: (2009)

Preventing transmission of maternally inherited mitochondrial DNA diseases.
de réir: Poulton, J, et al.
Foilsithe / Cruthaithe: (2009)

Preventing transmission of maternally inherited mitochondrial DNA diseases
de réir: Poulton, J, et al.
Foilsithe / Cruthaithe: (2009)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
de réir: Alexandros Briasoulis, et al.
Foilsithe / Cruthaithe: (2022-02-01)

DNA damage independent inhibition of NF-κB transcription by anthracyclines
de réir: Angelo Ferreira Chora, et al.
Foilsithe / Cruthaithe: (2022-12-01)

A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer
de réir: Lucia D’Amico, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments
de réir: Guoxia Zhang, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
de réir: Carmelita Abrahams, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment.
de réir: Chabita Saha, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Dexrazoxane in anthracycline cardiotoxicity
de réir: Abhijit S Nair
Foilsithe / Cruthaithe: (2017-01-01)

Anthracycline-Induced Cardiotoxicity
de réir: Radomír Hrdina, et al.
Foilsithe / Cruthaithe: (2000-01-01)

A longitudinal evaluation of oxidative stress - mitochondrial dysfunction - ferroptosis genes in anthracycline-induced cardiotoxicity
de réir: Ren Qianqian, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Molecular assessment of drug-phospholipid interactions consequent to cancer treatment: a study of anthracycline-induced cardiotoxicity
de réir: Yara Ahmed, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity
de réir: Carmine Rocca, et al.
Foilsithe / Cruthaithe: (2022-02-01)

A screen to identify drug resistant variants to target-directed anti-cancer agents
de réir: Azam Mohammad, et al.
Foilsithe / Cruthaithe: (2003-01-01)

A careful reassessment of anthracycline use in curable breast cancer
de réir: Sara Alsterlind Hurvitz, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines
de réir: Vivian I. Franco, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Anthracyclines in the treatment of early breast cancer friend or foe?
de réir: Ana Tecic Vuger, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
de réir: Neha Bansal, et al.
Foilsithe / Cruthaithe: (2019-12-01)